AU2003275495A1 - Methods of treating injuries of the nervous system associated with hemorrhage - Google Patents

Methods of treating injuries of the nervous system associated with hemorrhage

Info

Publication number
AU2003275495A1
AU2003275495A1 AU2003275495A AU2003275495A AU2003275495A1 AU 2003275495 A1 AU2003275495 A1 AU 2003275495A1 AU 2003275495 A AU2003275495 A AU 2003275495A AU 2003275495 A AU2003275495 A AU 2003275495A AU 2003275495 A1 AU2003275495 A1 AU 2003275495A1
Authority
AU
Australia
Prior art keywords
methods
nervous system
system associated
hemorrhage
treating injuries
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003275495A
Other languages
English (en)
Other versions
AU2003275495A8 (en
Inventor
Walter C. Low
Zhenhong Nan
Cecilia M. P. Rodriguez
Clifford J. Steer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Minnesota System
Original Assignee
University of Minnesota Twin Cities
University of Minnesota System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Minnesota Twin Cities, University of Minnesota System filed Critical University of Minnesota Twin Cities
Publication of AU2003275495A8 publication Critical patent/AU2003275495A8/xx
Publication of AU2003275495A1 publication Critical patent/AU2003275495A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
AU2003275495A 2002-11-07 2003-10-08 Methods of treating injuries of the nervous system associated with hemorrhage Abandoned AU2003275495A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US42521002P 2002-11-07 2002-11-07
US60/425,210 2002-11-07
US45161503P 2003-03-03 2003-03-03
US60/451,615 2003-03-03
PCT/US2003/031989 WO2004043342A2 (en) 2002-11-07 2003-10-08 Methods of treating injuries of the nervous system associated with hemorrhage

Publications (2)

Publication Number Publication Date
AU2003275495A8 AU2003275495A8 (en) 2004-06-03
AU2003275495A1 true AU2003275495A1 (en) 2004-06-03

Family

ID=32314576

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003275495A Abandoned AU2003275495A1 (en) 2002-11-07 2003-10-08 Methods of treating injuries of the nervous system associated with hemorrhage

Country Status (8)

Country Link
US (1) US20060135494A1 (cg-RX-API-DMAC7.html)
EP (1) EP1575578B1 (cg-RX-API-DMAC7.html)
JP (1) JP2006510740A (cg-RX-API-DMAC7.html)
KR (1) KR20050103185A (cg-RX-API-DMAC7.html)
AT (1) ATE451108T1 (cg-RX-API-DMAC7.html)
AU (1) AU2003275495A1 (cg-RX-API-DMAC7.html)
DE (1) DE60330501D1 (cg-RX-API-DMAC7.html)
WO (1) WO2004043342A2 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7772220B2 (en) 2004-10-15 2010-08-10 Seo Hong Yoo Methods and compositions for reducing toxicity of a pharmaceutical compound
US20030044413A1 (en) * 2000-08-15 2003-03-06 Regents Of The University Of Minnesota Methods of limiting apoptosis of cells
US20060204481A1 (en) * 2003-04-02 2006-09-14 Steer Clifford J Methods of promoting cell viability
ES2339790T3 (es) * 2004-08-30 2010-05-25 Seo Hong Yoo Efecto neuroprotector de udca solubilizado en modelo isquemico focal.
DE602005027727D1 (de) 2004-10-15 2011-06-09 Seo Hong Yoo Zusammensetzungen zur verringerung der toxizität von cisplatin, carboplatin und oxaliplatin
JP2008530100A (ja) * 2005-02-10 2008-08-07 リージェンツ オブ ザ ユニバーシティ オブ ミネソタ 視覚障害の治療方法
AU2007230989A1 (en) * 2006-03-22 2007-10-04 President And Fellows Of Harvard College Methods and compositions for treating hypercholesterolemia and atherosclerosis
KR20180029317A (ko) * 2016-09-12 2018-03-21 경상대학교산학협력단 간손상 예방, 개선 또는 치료용 조성물
KR101953298B1 (ko) * 2017-07-18 2019-02-28 의료법인 성광의료재단 우르소데옥시콜산을 함유하는 염증성 질환 또는 척수 손상 예방 또는 치료용 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2138971T3 (es) * 1991-07-03 2000-02-01 Otsuka Pharma Co Ltd Regulador de la apoptosis.
US5656725A (en) * 1995-05-12 1997-08-12 Apoptosis Technology, Inc. Peptides and compositions which modulate apoptosis
WO1999015179A1 (en) * 1997-09-25 1999-04-01 Regents Of The University Of Minnesota Methods of limiting apoptosis of cells
WO1999043336A1 (en) * 1998-02-27 1999-09-02 Nutramax Laboratories, Inc. L-ergothioneine, milk thistle, and s-adenosylmethionine for the prevention, treatment and repair of liver damage
GB0019290D0 (en) * 2000-08-04 2000-09-27 Symphar Sa Methods for inducing apolipoprotein E secretion
US20030044413A1 (en) * 2000-08-15 2003-03-06 Regents Of The University Of Minnesota Methods of limiting apoptosis of cells

Also Published As

Publication number Publication date
HK1086479A1 (zh) 2006-09-22
EP1575578A2 (en) 2005-09-21
KR20050103185A (ko) 2005-10-27
DE60330501D1 (de) 2010-01-21
WO2004043342A3 (en) 2004-07-15
JP2006510740A (ja) 2006-03-30
AU2003275495A8 (en) 2004-06-03
EP1575578A4 (en) 2007-10-10
EP1575578B1 (en) 2009-12-09
ATE451108T1 (de) 2009-12-15
WO2004043342A2 (en) 2004-05-27
US20060135494A1 (en) 2006-06-22

Similar Documents

Publication Publication Date Title
EP4245367A3 (en) Methods for treating cholestasis
ZA200810113B (en) Method for the treatment and prevention of ocular disorders
WO2004069190A3 (en) Combination therapy for treating protein deficiency disorders
WO2004017904A3 (en) Corticosteroid conjugates and uses thereof
WO2007092312A3 (en) Topical skin treating compositions
BRPI0411319A (pt) compostos terapeuticamente ativos e sua utilização
AU2003219107A1 (en) Tuberculosis treatment using pleuromutilin derivatives
WO2006015259A3 (en) Compounds and compositions as modulators of steroid hormone nuclear receptors
EP1651161A4 (en) PHARMACEUTICAL COMPOSITIONS AND METHOD FOR ACCELERATING WOUND HEALING
WO2005016286A8 (en) Pyrazine modulators of cannabinoid receptors
WO2004110380A3 (en) Treatment of immune-mediated disorders with active vitamin d compounds alone or in combination with other therapeutic agents
WO2007002831A3 (en) Topical skin treating compostions
WO2003088923A3 (en) Methods of treating ileus
SI1467706T1 (sl) Dermalni sistem za nanašanje derivatov aminolevulinske kisline
WO2008079270A3 (en) Coadministration of alpha-fetoprotein and an immunomodulatory agent to treat multiple sclerosis
WO2004043456A8 (en) Cholesterol absorption inhibitors for the treatment of demyelination
PL1694354T3 (pl) Sposób zapobiegania i leczenia cukrzycy za pomocą neurturyny
AU2003275495A8 (en) Methods of treating injuries of the nervous system associated with hemorrhage
WO2005077968A3 (en) 17-methylene-or 17 - spiro - cyclopropane 7 - substituted estra - 1, 3, 5 (10) - triene derivatives with anti - estrogenic activity
WO2005051331A3 (en) Chaperone-based therapy for niemann-pick disease
WO2003006063A3 (en) Formulation comprising fulvestrant
DE60015508D1 (de) C-16 ungesätigte fp-selektive prostaglandin analoge
WO2005048927A3 (en) Methods and reagents for the treatment of inflammatory disorders
WO2003094367A3 (en) Improved first aid kit instructions
WO2004064766A3 (en) Method of treatment of conditions by administration of streptolysin o

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase